Related Experiment Videos
Cross-tolerance between endogenous nitric oxide and exogenous nitric oxide donors
A Papapetropoulos1, N Marczin, J D Catravas
1Vascular Biology Center and Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912-2500, USA.
European Journal of Pharmacology
|May 26, 1998
Summary
This study investigated nitric oxide (NO) donor tolerance in aortic smooth muscle cells. Findings show cross-tolerance develops between endogenous NO and exogenous NO donors, impacting cellular responses.
Area of Science:
- Cardiovascular Biology
- Pharmacology
- Cellular Physiology
Background:
- Nitric oxide (NO) plays a crucial role in vascular homeostasis.
- The development of tolerance to NO donors is not fully understood.
- Investigating cross-tolerance is essential for understanding NO signaling pathways.
Purpose of the Study:
- To determine if cross-tolerance develops between endogenous NO and exogenous NO donors.
- To investigate the mechanisms of tolerance in aortic smooth muscle cells.
- To assess the impact of inflammatory stimuli on NO-induced responses.
Main Methods:
- Cultured aortic smooth muscle cells from various species (human, rat, rabbit, porcine, bovine) were used.
- cGMP accumulation was measured following exposure to sodium nitroprusside (SNP) and other NO donors.
- Cross-tolerance was assessed using different NO-releasing agents and co-culture models.
Main Results:
- Sodium nitroprusside induced a time- and concentration-dependent tolerance in smooth muscle cells.
- Cross-tolerance was observed between SNP and S-nitroso-N-acetylpenicillamine, but not atriopeptin.
- Endotoxin and IL-1beta pre-treatment reduced SNP-induced cGMP accumulation.
- Pre-exposure to SNP decreased responsiveness to endothelium-derived NO in co-cultures.
Conclusions:
- Cross-tolerance between endothelium-derived NO and exogenous NO donors occurs in vitro.
- Aortic smooth muscle cells can develop tolerance to NO signaling.
- These findings have implications for understanding vascular function and therapeutic interventions involving NO.